Skip to main content

The CTD² Network and Cancer Systems Biology Consortium organized a virtual symposium series titled “Multidisciplinary Approaches to Understand Cancer Treatment Resistance”. Please join us on 11/16, 11/17, 12/2, 12/16, and 12/17. Click here to view the registration website.

Publications

644 Publications Available
Cell Reports

Researchers find that autocrine IL6 secretion may contribute to MAPK inhibitor resistance in BRAF-mutant cells.

Clinical Cancer Research

The authors used a functional kinomics approach to identify novel survival kinases involved in G2-M cell-cycle checkpoint, SFK, PI3K, and FAK pathways in head and neck squamous cell carcinoma.

Journal of Surgical Research

The authors developed a method to grow lung cancer cells in a 4D model which enables the isolation of circulating tumor cells that are responsible for metastasis and analysis in comparison to 2D culture cells.

Genes and Development

By screening a custom library of shRNAs directed toward known drug targets in a genetically defined Myc-driven HCC model, researchers identified cyclin-dependent kinase 9 (Cdk9) as required for disease maintenance of hepatocellular carcinoma.

Cancer Cell

A review of a recent finding connecting the genes GF1 and GF1B in medulloblastoma.

Nature Protocols

Researchers develop protocol to construct genetic interaction map through two-stage approach.

Cell

The authors performed an integrative analysis on 3,527 specimens from 12 cancer types, revealing a unified classification into 11 major subtypes.

Neuro-Oncology

In this review researchers describe basic and translational research into glioma proliferation and invasion, in particular the phenotypic switch underlying a stochastic "go or grow" model of tumor cell behavior.

The Journal of Experimental Medicine

Researchers discuss the emerging themes of CAF biology in the context of tumorigenesis and therapy.

Cancer Research

The results suggest RAC1 P29S status may offer a predictive biomarker for RAF inhibitor resistance in melanoma patients.